Colin D. Funk
Colin D. Funk publishes mostly in Molecular Biology, Pharmacology and Immunology, on topics such as Inflammatory mediators and NSAID effects, Eicosanoids and Hypertension Pharmacology and Peroxisome Proliferator-Activated Receptors.
- World rank
- #128,913 of 7,710,434 ranked researchers
- Rank in Canada
- #4,185 of 183,316
- Works
- 227
- Citations
- 22k
- Citations per work
- 97.0
What does Colin D. Funk research?
Colin D. Funk's work is mostly in Biochemistry, Genetics and Molecular Biology (32%), Medicine (18%), Immunology and Microbiology (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else9541.9%
- Life Sciences9240.6%
- Health Sciences4017.5%
- Medicine4017.5%
- 1Molecular Biology18% of their works
- 2Pharmacology9% of their works
- 3Immunology9% of their works
- 4Physiology8% of their works
- 5Biochemistry8% of their works
- 6Genetics6% of their works
Research topics
- Inflammatory mediators and NSAID effects
- Eicosanoids and Hypertension Pharmacology
- Peroxisome Proliferator-Activated Receptors
- Asthma and respiratory diseases
- Estrogen and related hormone effects
- Atherosclerosis and Cardiovascular Diseases
- Nitric Oxide and Endothelin Effects
- Metabolism and Genetic Disorders
Which keywords describe Colin D. Funk's research?
The keywords of their largest research topics: Inflammation, Metabolism, Nuclear Receptors, Transcriptional Regulation, Cancer, Cyclooxygenase-2 Inhibitors, Arachidonic Acid and Epoxyeicosatrienoic Acids.
- Biochemical Genetics
- Nitric Oxide
- Endothelial Dysfunction
- Receptor
- Peroxisome Proliferator-Activated Receptors
- Asthma
- Epoxyeicosatrienoic Acids
- Cyclooxygenase-2 Inhibitors
- Transcriptional Regulation
- Metabolism
- Inflammation
- Nuclear Receptors
- Cancer
- Arachidonic Acid
- Allergic Diseases
- PPARs
- Estrogen
- Atherosclerosis
- Immune Response
- Oxidized LDL
- Metabolic Disorders
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Inflammation1936 topics
- Metabolism762 topics
- Nuclear Receptors612 topics
- Transcriptional Regulation612 topics
- Cancer591 topic
- Cyclooxygenase-2 Inhibitors591 topic
- Arachidonic Acid421 topic
- Epoxyeicosatrienoic Acids421 topic
- Allergic Diseases341 topic
- Asthma341 topic
- PPARs341 topic
- Peroxisome Proliferator-Activated Receptors341 topic
- Estrogen271 topic
- Receptor271 topic
- Atherosclerosis242 topics
- Endothelial Dysfunction121 topic
- Immune Response121 topic
- Nitric Oxide121 topic
- Oxidized LDL121 topic
- Biochemical Genetics111 topic
- Metabolic Disorders111 topic
Where does Colin D. Funk work?
Colin D. Funk's main affiliation in the publication record is Queen's University, Canada.
How many publications and citations does Colin D. Funk have?
OpenAlex counts 227 works and 22,011 citations for Colin D. Funk, an h-index of 72, ranking #128,913 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Colin D. Funk. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.